PAUL MASCI, DO
Hematology & Oncology Physician · WOOSTER, OH
Individual Active NPI 1366408627
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 446 | 228,885 | $31,048,634 | $5,914,789 | $4,705,708 |
| 2023 | 463 | 307,729 | $32,840,457 | $6,188,802 | $4,917,839 |
| 2022 | 398 | 188,112 | $26,708,821 | $4,944,636 | $3,933,532 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 27,020 | $31 | $25 |
| J1756 | Injection, iron sucrose, 1 mg | 24,200 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 14,000 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 9,600 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 3,480 | $25 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,710 | $0 | $0 |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,740 | $21 | $16 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,670 | $1 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,496 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 888 | $14 | $11 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 613 | $116 | $91 |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 600 | $67 | $53 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 34008048 | OH |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Ohio
- NPI 1851335822
- NPI 1578529749
- NPI 1598720708
- NPI 1174630008
- NPI 1770581787
- NPI 1376715284
- NPI 1922254937
- NPI 1134712896
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.